Hester Pharmaceuticals Limited

To advertise here email us on [email protected]


Contact Information
Company Name Hester Pharmaceuticals Limited
Contact Person
Address Village: Merda-Ardraj, Taluka:Kadi
Mehsana, Gujarat, India.
Zip / Postal Code 382721
Telephone 02764-285502/285454
Fax 02764-285673
Email Click here to email us
Website www.hesterpharma.com
Description Press Releases

    * Hester has reported a turnover of Rs. 9.21 crores in Q1 ended 30.6.2009 as compared to Rs. 9.00 crores for the previous corresponding period.
      Press Release (July 10, 2009), pdf 26.4 KB

    * The company's turnover was recorded at Rs.30.16 crores for the year ended 31.3.2009, as compared to turnover of Rs.32.63 crores for the year ended 31.3.2008 down by 7.57%.
      Press Release (June 30, 2009), pdf 27.4 KB

    * For the 9 months results ended 31.12.2008, Hester has reported a turnover of Rs. 22.09 crores as compared to Rs. 26.17 crores for the previous corresponding period.
      Press Release (Jan 20, 2008), pdf 27 KB

    * Hester introduces a Broad Spectrum CORYZA DISEASE VACCINE for the chicken.
      Press Release (Dec 22, 2008), pdf 27.3 KB

    * Hester has reported a turnover of Rs. 15.02 crores in H1 ended 30.9.2008 as compared to Rs. 17.33 crores for the previous corresponding period.
      Press Release (Oct 24, 2008), pdf 27.3 KB

    * Hester Biosciences registers a growth of 37% in Net Profit and 92% in Cash Profit on a 50% growth in Sales over last year
      Press Release (June 24, 2008), pdf 32 KB

    * We hereby inform you that with immediate effect, our company's name has changed from "Hester Pharmaceuticals limited" to "Hester Biosciences Limited"
      Press Release (Apr 24, 2008), pdf 54 KB

    * Highlights of 9 months ended on 31.12.2007, Change in name of company, Change of Board member
      Press Release (Jan 21, 2008), pdf 102 KB

    * Hester has reported a trunover of Rs. 17.33 crores in H1 ended 30.9.7 as compared to Rs 10.55 crores.
      Press Release (Oct 18, 2007), pdf 54.6 KB

    * Hester Pharma registers a growth of 16.17% in Net Profit on a 8.45% growth in Sales over last year. Has recommended a 20% dividend for the year 2006-2007, 400% expanded capacity on-stream.
      Press Release (March 31, 2007), pdf 8.49 KB

    * Hesterís Net Profit for Q2 ended 30.9.2006 is recorded at Rs. 1.37 crores.
      Press Release (October 31, 2006), pdf 8.49 KB

    * Hesterís Net Profit for Q1 ended 30.6.2006  recorded at Rs. 1.21 crores.
      Press Release (July 31, 2006), pdf 12.8 KB

    * Hester Pharma declares 15% dividend.
      Press Release (July 14, 2006), pdf 16 KB

    * Hester Pharmaís RIGHTS ISSUE opens on 27.6.2006
      Press Release (June 14, 2006), pdf 10 KB

    * The Bird Flu problem, if tackled at the poultry level itself, could eliminate the risk of humans being affected by it.
      Press Release (Feb 20, 2006), pdf 12 KB

    * Highlights of 9 months Audited results, ended on 31.12.2005
      Press Release (Jan 1, 2006), pdf 60 KB

    * Hesterís Board proposes Preferential allotment at Rs. 150 per share and Rights at Rs. 70 per share.
      Press Release (Nov 15, 2005), pdf 10 KB

    * HESTER PHARMA registers a growth of 269% in Net Profit and 111% in Sales over last year.
      Press Release (Apr 21, 2005), pdf 13 KB

    * HESTER PHARMA has recommended a 12% dividend for the year 2004-2005 -
      Press Release (Apr 21, 2005), pdf 13 KB

    * HESTER PHARMA Embarks on an expansion plan.
      Press Release (Apr 21, 2005), pdf 13 KB

    * HESTER PHARMA registers a growth of 348% in Net Profit and 120% in Sales.
      Press Release (Jan 21, 2005), pdf 52 KB
    * MERIAL appoints HESTER PHARMACEUTICALS as their exclusive distributor in India for poultry vaccines - Ahmedabad (July 1, 2004) pdf 107 KB

    * HESTERís Profit Before Tax zooms 418% -
      Press Release (Dec 30, 2004), pdf 46 KB

    * Hester Pharma opens Administrative & Sales Office in Namakkal - Namakkal (May 28, 2001) pdf 9.34 KB

    * Hester Pharmaceuticals to market Poultry Coccidiosis vaccine from BIOPHARM, of Czech Republic - Ahmedabad (Sept 3, 2001) pdf 7.24 KB

    * Sinsui To Source Poultry Vaccines From Hester Pharmaceuticals - Ahmedabad (sept. 20, 2000) pdf 10.9 KB

    * Hester Pharmaceuticals introduces Ten new Poultry Vaccines in the Indian Market - Ahmedabad (Nov. 20, 2000) pdf 12.8 KB


Live Vaccines
Live B1
Newcastle Disease Vaccine (B1 strain)
A lyophilized vaccine of chick embryo origin, B1 strain is a lentogenic strain of Newcastle disease vaccine suitable for primary vaccination. (Available in 200, 500, 1000, 2000 & 5000 doses.)
Live LAS
Newcastle Disease Vaccine (LaSota Strain)
A lyophilized vaccine of chick embryo origin, LaSota strain is a lentogenic strain of Newcastle disease vaccine suitable for primary and booster vaccination. (Available in 200, 500,1000, 2000 & 5000 doses.)
Live R2B
Newcastle Disease Vaccine (R2B - Mukhteshwar Strain)
A lyophilized vaccine of chick embryo origin, R2B strain is a mesogenic strain of Newcastle disease vaccine suitable for booster vaccination, especially in tropical countries.(Available in 400 & 1000 doses.)
Live M48
Bronchitis Vaccine (Mild Mass. Type)
A lyophilized vaccine of chick embryo origin, Massachusetts Strain is a mild strain of Infectious Bronchitis vaccine suitable for primary and booster vaccination. (Available in 200, 500, 1000, 2000 & 5000 doses.)
Live B1-M48
Newcastle-Bronchitis Vaccine, B1 Type, B1 Strain-Mass. Type - Live Virus
A lyophilized vaccine of CEO virus (freeze-dried) in vials and sealed under vacuum to preserve stability. It is supplied with or without diluent. (Available in 200, 500, 1000, 2000 and 5000 doses per vial.)
Live LAS-MAS
New castle (LaSota Strain)-Bronchitis (Mass type).
A lyophilized vaccine of chick embryo origin, LaSota and Massachusetts strains are mild strains of Newcastle disease and Bronchitis virus vaccine suitable for booster vaccination. (Available in 200, 500, 1000, 2000 & 5000 doses.)
Live FP
Fowl Pox Vaccine
A lyophilized vaccine of tissue culture origin, Fowl Pox strain is an attenuated strain of Fowl Pox virus suitable for primary and booster vaccination. (Available in 500 & 1000 doses.)
Gumboro M1
Infectious Bursal Disease Vaccine (Mild - Standard Type 1)
A lyophilized vaccine of chick embryo origin, M1 is a mild strain of standard type 1 IBD virus suitable for primary vaccination of chicks with low or negligible levels of maternal antibody. (Available in 500, 1000 & 2000 doses.)
Gumboro I
Infectious Bursal Disease Vaccine (Intermediate - Standard Type1)
A lyophilized vaccine of chick embryo origin, Gumboro I is an intermediate strain of standard type 1 IBD virus suitable for primary vaccination of chicks with low to moderate levels of maternal antibody and for booster vaccination. (Available in 200, 500, 1000, 2000 & 5000 doses.)
Gumboro I+
Infectious Bursal Disease Vaccine, Standard Type 1, Intermediate invasive Strain - Live Virus
A lyophilized CEO virus vaccine.(freeze-dried) in vials and sealed under vacuum to preserve stability. It is supplied with or without diluent. (Available in 200, 500, 1000, 2000 and 5000 doses per vial.)
Marekís Disease Vaccine
Turkey Herpes Virus- FC 126 strain.
A lyophilized vaccine of tissue culture origin, the FC 126 strain of Turkey Herpes Virus is suitable for vaccination of 1 day old chicks.(Available in 500, 1000 & 2000 doses.)
Last Updated: 2009-09-15 01:01:45  
See something wrong?Please mail to [email protected]
Go Back
Categorys listing
The company ' Hester Pharmaceuticals Limited ' is listed in our Yellow Pages section in the following Categories and Sub Categories.
Pharmaceuticals
Pharmaceuticals - Manufacturers